Such capsid variants that efficiently penetrate the primate BBB will facilitate the production of neurodegenerative disease models of NHPs including SCA3 and will contribute to develop therapeutics against the neurodegenerative diseases. Here, ATXN3 is linked to neurodegenerative disease.